OSCR
Oscar Health Inc
$32.25+0.03%
Setup
Near pivot
Buy Zone
$31.37-$32.94
Sector
Healthcare Plans
Industry
Healthcare Plans
85
Recommendation
Watch
Hold
Quality acceptable but no fresh entry signal.
OSCR chart
Loading chart…
Overall Quality85
RS Rating
86
relative strength
Fundamentals
82
Strong fund-Q
Volume Demand
82
-38% vs avg
Technical Setup
88
7/8 checks
Industry/Theme
91
Healthcare Plans
Trade Plan
Watch
Entry
$31.37
Entry Zone
$31.37-$32.94
Stop / Risk
$28.86
RS Rating
86
Volume confirmed
Yes
Targets
$37.64 / $39.21
Breakout · IBD Setup
8 ✓
Entry $31.37–$32.94Stop $28.86Target $37.64 / $39.21
Market regimeUptrend
Quality85
RS Rating86
Above 50-MA+6.07%
Above 200-MA+57.41%
VolumeConfirmed
In Buy ZoneYes
Not extendedOK
Invalidation · Close below stop
How this came together
85
MarketUptrend
SetupNear pivot
ConfidenceExperimental · not backtested
Fund-Q82 · Strong
StatusHold
Stock Data
52-Week Range11 – 34
Price % Chg YTD124.43%
Price % Chg 4wk21.51%
50-Day Avg Vol5.9 Mil
P/E Ratio23.6
Market Cap$10B
SectorHealthcare
IndustryHealthcare Plans
Company Fundamentals
EPS % Chg (Qtr)221.42%
Sales % Chg (Qtr)70.4%
EPS Growth 5y0.13%
Sales Growth 5y90.8%
Annual ROE34.31%
Gross Margin—
Operating Margin4.11%
Net Margin3.6%
Debt / Equity0.21
Setup levels
Current price
$32.25
Pivot
$31.37
Distance to buy
-3.9%
52-week range
10.69-33.55
Trigger evidence
No active trigger evidence available.
Financial health checks
4/5
Return on equity above 15%
ROE 34.31%
Net margin above 10%
Net margin 3.6%
EPS growing quarter on quarter
EPS q/q 221.42%
Sales growing quarter on quarter
Sales q/q 70.4%
Debt to equity below 1.0
D/E 0.21
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE34.31%
vs sector +12.2%
Net margin3.6%
vs sector -13.4%
Gross margin—
EPS growth q/q221.42%
vs sector +213.4%
Sales growth q/q70.4%
vs sector +51.9%
Debt / equity0.21
vs sector -0.43
Business quality
82
GradeStrong
EPS rating87
P/E23.6
Market cap$10B
IndustryHealthcare Plans
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Pass
In Kaufzone
Pass
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-09-03
Trigger date
—
Days on list
4
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.